1Portier P, Richet C. De l'action anaphylactique de certains venins[J]. C. r. Soc. Biol (Paris), 1902,54:170-173
2Rusznak C, Peebles RS Jr. Anaphylaxis and anaphylactoid reactions A guid to prevention, recognition, and emergent treatment[J]. Postgrad Med, 2002,111 (5) : 101-114
3Terencem O,Conner,Joseph O,et al. The role of substance P in inflammatory disease[J].J Cell Physiol, 2004,201 (2):167-180
4Maggi CA. The effects of tachykinins on inflammatory and immune cells[J]. Regul Pept, 1997,70(2-3):75-90
5Maggio JE. "Kassinin" in mammals: the newest tachykinins [J].Peptides, 1985,6 (3) : 237-243
6Fan TP, Hu DE, Guard S, et al. Stimulation of angiogenesls by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists[J]. Br J Pharmacol, 1993,110( 1 ): 43-49
7Tahara E,Satoh T,Watanabe C,et al. A third-phase cutaneous(very late phase)response after elicitation with dinitrofluorobenzene in passively or actively sensitized mice [J], Allergol Int, 1999,48(3):265-273
8Hamel R, Ford-Hutchinson AW, Blazejczak C, et al. Tachykinin involvement in cutaneous anaphylaxis in the guinea pig[J]. Can J Physiol Phamacol,1998,66(11) : 1361-1367
9Kim KH,Park KC,Chung JH ,et al. The effect of substance P on peripheral blood mononuclear cells in patients with atopic dermatitis[J], J Dermatol Sci,2003,32(2) : 115-124
3Kang H,Byun D G,Kim J W.Effects of substance p and vasoactive intestinal peptide on interferon -gamma and interleukin -4 production in severe atopic dermatitis[J].Ann Allergy Immunol,2000,85 (3):227-232.
4Canning B J,Fischer A.Neural regulation of airway smooth muscle tone[J].Respir-Physiol,2001,125 (1-2):113-127.
